U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Third Synthesis Inc., dba Chicago Sweet Connections, Inc. - 633453 - 05/25/2023
  1. Warning Letters

CLOSEOUT LETTER

Third Synthesis Inc., dba Chicago Sweet Connections, Inc. MARCS-CMS 633453 —

Delivery Method:
VIA Electronic Mail
Product:
Food & Beverages
Recipient:
Recipient Name
Athanasios D. Kailis
Recipient Title
President/CEO/Owner
Third Synthesis Inc., dba Chicago Sweet Connections, Inc.

5569 N. Northwest Highway
Chicago, IL 60630
United States

PKailis@sweetconnectionbakery.com
Issuing Office:
Division of Human and Animal Food Operations East VI

United States

Dear Mr. Kailis:

The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter FY22-HAFE6-WL-06. Based on our evaluation, it appears that you have addressed the violation(s) contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,
/S/
Kelli Wilkinson LCDR
Director of Compliance
Office of Human and Food Operations
Division East 6

Back to Top